Stryker (LTS:0R2S) Other Current Payables: $337 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0R2S Stryker Corp LTS:0R2S
89 GF Score
Price $329.27
GF Value $411.03
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Stryker Other Current Payables?

Stryker LTS:0R2S +4.64% 89 Other Current Payables is $337 Mil as of Mar. 2026. GuruFocus rates LTS:0R2S with a GF Score™ of 89/100 and a GF Value™ of $411.03 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Stryker's Other Current Payables for the quarter that ended in Mar. 2026 was $337 Mil.

Stryker's quarterly Other Current Payables increased from Sep. 2025 ($321 Mil) to Dec. 2025 ($337 Mil) but then stayed the same from Dec. 2025 ($337 Mil) to Mar. 2026 ($337 Mil).

Stryker's annual Other Current Payables increased from Dec. 2023 ($304 Mil) to Dec. 2024 ($320 Mil) and increased from Dec. 2024 ($320 Mil) to Dec. 2025 ($337 Mil).

Stryker Other Current Payables Related Terms

Stryker Other Current Payables Historical Data

* Premium members only.

The historical data trend for Stryker's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stryker Other Current Payables Chart

Stryker Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 263.00 284.00 304.00 320.00 337.00

Stryker Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 320.00 321.00 321.00 337.00 337.00
LTS:0R2S
89GF Score
Stryker Corp LTS:0R2S
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stryker Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $337 Mil mean?
Stryker (LTS:0R2S) has a Other Current Payables of $337 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Stryker and its competitors.
Is Stryker's Other Current Payables too high?
Stryker's current Other Current Payables is $337 Mil. Overall, Stryker has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stryker's Other Current Payables compare to MDT and ABT?
Stryker's Other Current Payables of $337 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Stryker and its competitors. Stryker's current Other Current Payables is $337 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stryker stock overvalued right now?
Based on GuruFocus' analysis, Stryker (LTS:0R2S) is currently considered Modestly Undervalued. The stock's GF Value™ is $411.03, compared to a current price of $329.27 — trading 19.9% below its estimated fair value. The current Other Current Payables is $337 Mil. Stryker's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Stryker (LTS:0R2S), the current Other Current Payables is $337 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stryker (LTS:0R2S) Overvalued in 2026?

Based on GuruFocus' analysis, Stryker stock appears to be undervalued. The current stock price of $329.27 is trading 19.9% below its estimated GF Value™ of $411.03. GuruFocus considers Stryker to be Modestly Undervalued.

Key valuation signals for LTS:0R2S:

  • Other Current Payables: $337 Mil
  • GF Value™: $411.03 vs. price of $329.27 (19.9% below fair value)
  • GF Score™: 89/100 with 1 warning sign

No single metric tells the full story. See the LTS:0R2S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stryker Business Description

Address 1941 Stryker Way, Portage, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
89GF Score

Get the complete analysis for LTS:0R2S

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$329.27
Price
$411.03
GF Value